Compare AbCellera Biologics Inc (ABCL) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs KraneShares Electric Vehicles and Future Mobility — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while KraneShares Electric Vehicles and Future Mobility trades at $30.2. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.
| ABCL | KARS | |
|---|---|---|
Market Cap | $2.35B | — |
Sector | Health | Sector/Thematic |
52-Week High | $8.12 | $38.01 |
52-Week Low | $2.78 | $22.17 |
Enterprise Value | $1.99B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KARS trades at $31.79, up 1.18% with a bearish technical signal as moving averages indicate selling pressure. The electric vehicle ETF faces industry headwinds including shifting consumer demand and geopolitical tensions affecting fuel prices. Recent news highlights Chinese EV expansion and regulatory uncertainties in the US market, while technical indicators show neutral oscillators but strong bearish momentum from moving averages.
The outlook remains cautious with industry pressures from Chinese competition and regulatory delays. Investment opportunities exist in global EV adoption trends, but risks include tariff policies and demand volatility. Key support sits at $31 with resistance at $32, requiring close monitoring of auto industry developments and policy changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →
